Risk stratification model for in-hospital death in patients undergoing percutaneous coronary intervention: a nationwide retrospective cohort study in Japan

被引:22
作者
Inohara, Taku [1 ]
Kohsaka, Shun [2 ]
Yamaji, Kyohei [3 ]
Ishii, Hideki [4 ]
Amano, Tetsuya [5 ]
Uemura, Shiro [6 ]
Kadota, Kazushige [7 ]
Kumamaru, Hiraku [8 ]
Miyata, Hiroaki [8 ]
Nakamura, Masato [9 ]
机构
[1] Keio Univ Hosp, Dept Cardiol, Shinjuku Ku, Tokyo, Japan
[2] Japanese Assoc Cardiovasc Intervent & Therapeut, Tokyo, Japan
[3] Kokura Mem Hosp, Div Cardiol, Kitakyushu, Fukuoka, Japan
[4] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi, Japan
[5] Aichi Med Univ, Dept Cardiol, Nagakute, Aichi, Japan
[6] Kawasaki Med Sch, Dept Cardiol, Kurashiki, Okayama, Japan
[7] Kurashiki Cent Hosp, Dept Cardiol, Kurashiki, Okayama, Japan
[8] Toho Univ, Ohashi Med Ctr, Natl Clin Database, Div Cardiovasc Med, Tokyo, Japan
[9] Toho Univ, Ohashi Med Ctr, Tokyo, Japan
来源
BMJ OPEN | 2019年 / 9卷 / 05期
基金
日本学术振兴会;
关键词
ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; DUAL ANTIPLATELET THERAPY; LONG-TERM MORTALITY; SMOKING STATUS; TASK-FORCE; OUTCOMES; SCORE; PREDICTION; IMPACT;
D O I
10.1136/bmjopen-2018-026683
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To provide an accurate adjustment for mortality in a benchmark, developing a risk prediction model from its own dataset is mandatory. We aimed to develop and validate a risk model predicting in-hospital mortality in a broad spectrum of Japanese patients after percutaneous coronary intervention (PCI). Design A retrospective cohort study was conducted. Setting The Japanese-PCI (J-PCI) registry includes a nationally representative retrospective sample of patients who underwent PCI and covers approximately 88% of all PCIs in Japan. Participants Overall, 669 181 patients who underwent PCI between January 2014 and December 2016 in 1018 institutes. Main outcome measures In-hospital death. Results The study population (n=669 181; mean (SD) age, 70.1(11.0) years; women, 24.0%) was divided into two groups: 50% of the sample was used for model derivation (n=334 591), while the remaining 50% was used for model validation (n=334 590). Using the derivation cohort, both 'full' and 'preprocedure' risk models were developed using logistic regression analysis. Using the validation cohort, the developed risk models were internally validated. The in-hospital mortality rate was 0.7%. The preprocedure model included age, sex, clinical presentation, previous PCI, previous coronary artery bypass grafting, hypertension, dyslipidaemia, smoking, renal dysfunction, dialysis, peripheral vascular disease, previous heart failure and cardiogenic shock. Angiographic information, such as the number of diseased vessel and location of the target lesion, was also included in the full model. Both models performed well in the entire validation cohort (C-indexes: 0.929 and 0.926 for full and preprocedure models, respectively) and among prespecified subgroups with good calibration, although both models underestimated the risk of mortality in high-risk patients with the elective procedure. Conclusions These simple models from a nationwide J-PCI registry, which is easily applicable in clinical practice and readily available directly at the patients' presentation, are valid tools for preprocedural risk stratification of patients undergoing PCI in contemporary Japanese practice.
引用
收藏
页数:10
相关论文
共 31 条
  • [1] American College of Cardiology percutaneous coronary intervention (PCI) readmission measure, MED HOSP COMP
  • [2] [Anonymous], 2012, Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2012
  • [3] Enhanced Mortality Risk Prediction With a Focus on High-Risk Percutaneous Coronary Intervention Results From 1,208,137 Procedures in the NCDR (National Cardiovascular Data Registry)
    Brennan, J. Matthew
    Curtis, Jeptha P.
    Dai, David
    Fitzgerald, Susan
    Khandelwal, Akshay K.
    Spertus, John A.
    Rao, Sunil V.
    Singh, Mandeep
    Shaw, Richard E.
    Ho, Kalon K. L.
    Krone, Ronald J.
    Weintraub, William S.
    Weaver, W. Douglas
    Peterson, Eric D.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (08) : 790 - 799
  • [4] The Toronto score for in-hospital mortality after percutaneous coronary interventions
    Chowdhary, Saqib
    Ivanov, Joan
    Mackie, Karen
    Seidelin, Peter H.
    Dzavik, Vladimir
    [J]. AMERICAN HEART JOURNAL, 2009, 157 (01) : 156 - 163
  • [5] Erne P, 2015, J HYPERTENS, V33, P860, DOI 10.1097/HJH.0000000000000343
  • [6] Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States
    Fanaroff, Alexander C.
    Zakroysky, Pearl
    Dai, David
    Wojdyla, Daniel
    Sherwood, Matthew W.
    Roe, Matthew T.
    Wang, Tracy Y.
    Peterson, Eric D.
    Gurm, Hitinder S.
    Cohen, Mauricio G.
    Messenger, John C.
    Rao, Sunil V.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (24) : 2913 - 2924
  • [7] Smoker's Paradox in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Gupta, Tanush
    Kolte, Dhaval
    Khera, Sahil
    Harikrishnan, Prakash
    Mujib, Marjan
    Aronow, Wilbert S.
    Jain, Diwakar
    Ahmed, Ali
    Cooper, Howard A.
    Frishman, William H.
    Bhatt, Deepak L.
    Fonarow, Gregg C.
    Panza, Julio A.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (04):
  • [8] The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel The PARADOX Study
    Gurbel, Paul A.
    Bliden, Kevin P.
    Logan, Douglas K.
    Kereiakes, Dean J.
    Lasseter, Kenneth C.
    White, Alex
    Angiolillo, Dominick J.
    Nolin, Thomas D.
    Maa, Jen-Fue
    Bailey, William L.
    Jakubowski, Joseph A.
    Ojeh, Clement K.
    Jeong, Young-Hoon
    Tantry, Udaya S.
    Baker, Brian A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (06) : 505 - 512
  • [9] The New York State Risk Score for Predicting In-Hospital/30-Day Mortality Following Percutaneous Coronary Intervention
    Hannan, Edward L.
    Farrell, Louise Szypulski
    Walford, Gary
    Jacobs, Alice K.
    Berger, Peter B.
    Holmes, David R., Jr.
    Stamato, Nicholas J.
    Sharma, Samin
    King, Spencer B., III
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (06) : 614 - 622
  • [10] Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation - The J-ROCKET AF Study
    Hori, Masatsugu
    Matsumoto, Masayasu
    Tanahashi, Norio
    Momomura, Shin-ichi
    Uchiyama, Shinichiro
    Goto, Shinya
    Izumi, Tohru
    Koretsune, Yukihiro
    Kajikawa, Mariko
    Kato, Masaharu
    Ueda, Hitoshi
    Iwamoto, Kazuya
    Tajiri, Masahiro
    [J]. CIRCULATION JOURNAL, 2012, 76 (09) : 2104 - 2111